GENE ONLINE|News &
Opinion
Blog

2025-06-12|

Omega-3 Index Identified as Key Biomarker for Assessing Cardiovascular and Cognitive Health Risks

by Mark Chiang
Share To

Recent research highlights the significance of Omega-3 fatty acids, commonly referred to as n-3 FAs, in maintaining overall health. The findings emphasize their essential role in various physiological functions and underscore the importance of measuring these levels through the Omega-3 Index. This index serves as a biomarker for assessing the concentration of Omega-3 fatty acids in red blood cells, providing insights into an individual’s dietary intake and potential health outcomes.

The study delves into how adequate levels of Omega-3 fatty acids are linked to improved cardiovascular health, brain function, and inflammation regulation. Researchers also note that low Omega-3 Index scores may correlate with increased risks for chronic conditions such as heart disease and cognitive decline. The report suggests that monitoring this index could help individuals better understand their nutritional needs and guide dietary adjustments to optimize health.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: March 21, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Experts Discuss Tailored Long-Term Care Strategies for Tardive Dyskinesia, Parkinson’s, and Huntington’s Disease
2025-07-10
LATEST
Experts Discuss Tailored Long-Term Care Strategies for Tardive Dyskinesia, Parkinson’s, and Huntington’s Disease
2025-07-10
Biosynth Opens Expanded GMP Bioconjugation Facility in Germany to Support Drug Development
2025-07-10
Federal Cap on Medicaid Provider Taxes Could Impact Hospital Funding for Low-Income Populations
2025-07-10
Department of Health and Children’s National Hospital Partner to Advance Pediatric Cell and Gene Therapy
2025-07-10
Johnson & Johnson Seeks Approval to Expand Akeega Use for Hormone-Sensitive Prostate Cancer
2025-07-10
UCLA Health Researchers Identify Four Pathways in Alzheimer’s Development Through Electronic Health Records Analysis
2025-07-10
Podcast Explores Role of CDMOs in Early-Stage Drug Formulation and Clinical Transition
2025-07-10
EVENT
2025-07-23
BIO Asia–Taiwan 2025
Taipei, Taiwan
2025-08-08
HEALTHY AGEING TECH SHOW
Taipei, Taiwan
2025-08-09
MEDINFO 2025
Taipei, Taiwan
2025-09-03
BIO ASIA PACIFIC 2025
Bangkok, Thailand
2025-09-10
BIOHK 2025
Hong Kong
2025-10-01
Medical Japan 2025
Osaka, Japan
Scroll to Top